InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,203.20
(
0.19%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.55
(
0.52%
)
Bitcoin
66,232.54
(
-0.60%
)
Post# of 3329
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Er0ck

Send PM Follow Ignore
Followers 192
Posts 4375
Boards Moderated 1
Alias Born 08/27/2009

Er0ck

Re: Solantey post# 2192

Tuesday, 02/05/2013 9:12:32 AM

Tuesday, February 05, 2013 9:12:32 AM

Post# of 3329
Lol get real, this was trading around 3.40 before it shot up on the pump and the phase 3 trail results. This isn't over sold until its back under $4. It's still WAY to high for a company that doesn't even have a patent on it's drug, and is still 12 to 14 months away from a POSSIBLE FDA approval, and for a company that has no money and is diluting the stock to pay bills.

Even if you agree with everything here and "believe" in them, the stock it self is going to be worthless long before any drug hits the market due to the dilution.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up